Forbes.com: Pharma's Dilemma Is Biotech's Opportunity

From about.com:

"This article from Forbes explains how, when one takes relative size into consideration, small biotech's greatly outpace large pharmaceutical companies in innovation, and lays out the the current drug development landscape - scientific discovery being done in specialized firms and handed off to large generalists to commercialize."